Literature DB >> 8470724

Late complications after glaucoma filtering surgery with adjunctive 5-fluorouracil.

U Ticho1, A Ophir.   

Abstract

We studied 105 patients (105 eyes) operated on for glaucoma with adjunctive fluorouracil, who were followed up for 12 to 48 months (mean, 34.6 +/- 12.9 months). Fifty eyes that had previous glaucoma or cataract extraction or had inflammatory glaucoma had a high risk for postoperative scarring (high-risk group), and 55 eyes had glaucoma surgery as an initial procedure (initial surgery group). An intraocular pressure of 20 mm Hg or less, with or without hypotensive medications, was found in 42 eyes in the high-risk group (84.0%) and in 53 of the eyes in the initial surgery group (96.4%). Of the 105 eyes, an intraocular pressure of 12 mm Hg or less without medication was achieved in 17 eyes in the high-risk group (34.0%) and in 35 eyes in the initial surgery group (63.6%). Late complications in both groups were as follows: endophthalmitis in four eyes (3.8%) (two of the infected blebs were located superiorly and two inferiorly), transient leaking bleb in two eyes (1.9%), hypotony of an extended period with 180 to 360 degrees of filtration in three eyes (2.9%), giant bleb extending over the cornea in two eyes (1.9%), and a transient, mild iridocyclitis in nine eyes (8.6%). Thus, adjunctive fluorouracil after filtering surgery may entail various, mainly bleb-related, late side effects and complications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8470724     DOI: 10.1016/s0002-9394(14)74454-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Combined trabeculotomy and trabeculectomy: outcome for primary congenital glaucoma in a West African population.

Authors:  V A Essuman; I Z Braimah; T A Ndanu; C T Ntim-Amponsah
Journal:  Eye (Lond)       Date:  2010-11-05       Impact factor: 3.775

2.  Dose, timing and frequency of subconjunctival 5-fluorouracil injections after glaucoma filtering surgery.

Authors:  Eva Kristina Reinthal; Paul Oliver Denk; Matthias Grüb; Dorothea Besch; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-17       Impact factor: 3.117

3.  Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment.

Authors:  K Mochizuki; S Jikihara; Y Ando; N Hori; T Yamamoto; Y Kitazawa
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

4.  Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro.

Authors:  S Saika; A Ooshima; O Yamanaka; Y Okada; S Tanaka; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

5.  Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma.

Authors:  A Azuara-Blanco; R P Wilson; G L Spaeth; C M Schmidt; J J Augsburger
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

6.  Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.

Authors:  N Anand; S Arora; M Clowes
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

7.  Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.

Authors:  T Schlote; M Derse; M Zierhut
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

Review 8.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005.

Authors:  Joshua D Stein; David Ruiz; Daniel Belsky; Paul P Lee; Frank A Sloan
Journal:  Ophthalmology       Date:  2008-07       Impact factor: 12.079

10.  Outcomes of bleb excision and conjunctival advancement for leaking or hypotonous eyes after glaucoma filtering surgery.

Authors:  D P Tannenbaum; D Hoffman; M J Greaney; J Caprioli
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.